Characterization of EPO N-Glycans using RapiFluor-MS and HILIC Profiling
Applications | 2015 | WatersInstrumentation
Recombinant human erythropoietin (rhEPO) is a cornerstone therapy for anemia management, but its function and half-life are heavily influenced by the structures of its N-linked glycans. Detailed profiling of these glycans is critical for biosimilar development, quality control, and ensuring consistent therapeutic performance.
This study aimed to develop a streamlined workflow for rapid release, labeling, and characterization of EPO N-glycans using Waters GlycoWorks RapiFluor-MS chemistry coupled with hydrophilic interaction chromatography (HILIC) and high-resolution mass spectrometry. The goal was to achieve comprehensive glycan profiling in under 30 minutes of sample preparation with high sensitivity and resolution.
The approach leveraged a fast enzymatic deglycosylation protocol accelerated by RapiGest SF surfactant and Rapid PNGase F at 50 °C. Released glycosylamines were then tagged in five minutes with RapiFluor-MS, enhancing fluorescence yield and electrospray ionization efficiency. Labeled glycans were purified via HILIC µElution plates and eluted for direct analysis.
Použitá instrumentace:
HILIC-FLR-MS chromatograms revealed well-resolved peaks corresponding to various tetra-antennary N-glycans bearing three to four sialic acids and poly-N-acetyl lactosamine extensions. The predominant species, FA4G4S4, accounted for ~20 % of the glycan pool. Minor species included mono- and di-lactosamine-extended glycans (FA4G4Lac1S4 at ~12 % and FA4G4Lac2S4 at ~4.5 %), as well as tri- and tetra-lactosamine variants at trace levels (0.75 % and 0.25 %, respectively). High mass accuracy (<5 ppm) and enhanced sensitivity enabled confident assignments without multidimensional fractionation.
The RapiFluor-MS workflow compresses glycan sample preparation to 30 minutes while boosting detection limits through improved fluorescence and MS response. The single-dimension HILIC separation simplifies analysis and accelerates throughput, offering an efficient platform for biosimilar comparability studies, lot release testing, and detailed quality attribute monitoring in biopharmaceutical manufacturing.
Advancements may include integration with ultra-high-throughput automation, coupling with ion mobility for enhanced glycan isomer separation, and expansion to O-glycan analysis. Machine-learning-driven spectral interpretation could further streamline data processing and accelerate regulatory submissions for next-generation glycoprotein therapeutics.
The combination of rapid RapiFluor-MS labeling and HILIC-ESI-QTof-MS offers a sensitive, high-resolution method for characterizing complex EPO N-glycans. This single-dimension approach supports fast, reliable glycan profiling essential for therapeutic development and quality assurance of erythropoietin products.
Consumables, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS
IndustriesPharma & Biopharma
ManufacturerWaters
Summary
Significance of the Topic
Recombinant human erythropoietin (rhEPO) is a cornerstone therapy for anemia management, but its function and half-life are heavily influenced by the structures of its N-linked glycans. Detailed profiling of these glycans is critical for biosimilar development, quality control, and ensuring consistent therapeutic performance.
Objectives and Study Overview
This study aimed to develop a streamlined workflow for rapid release, labeling, and characterization of EPO N-glycans using Waters GlycoWorks RapiFluor-MS chemistry coupled with hydrophilic interaction chromatography (HILIC) and high-resolution mass spectrometry. The goal was to achieve comprehensive glycan profiling in under 30 minutes of sample preparation with high sensitivity and resolution.
Methodology and Instrumentation
The approach leveraged a fast enzymatic deglycosylation protocol accelerated by RapiGest SF surfactant and Rapid PNGase F at 50 °C. Released glycosylamines were then tagged in five minutes with RapiFluor-MS, enhancing fluorescence yield and electrospray ionization efficiency. Labeled glycans were purified via HILIC µElution plates and eluted for direct analysis.
Použitá instrumentace:
- GlycoWorks RapiFluor-MS N-Glycan Kit
- RapiGest SF surfactant and Rapid PNGase F enzyme
- HILIC µElution plate and SPE Elution Buffer
- ACQUITY UPLC I-Class System with Glycan BEH Amide column (2.1×150 mm, 1.7 µm, 130 Å)
- Xevo G2-S QTof mass spectrometer with positive mode ESI detection
Key Results and Discussion
HILIC-FLR-MS chromatograms revealed well-resolved peaks corresponding to various tetra-antennary N-glycans bearing three to four sialic acids and poly-N-acetyl lactosamine extensions. The predominant species, FA4G4S4, accounted for ~20 % of the glycan pool. Minor species included mono- and di-lactosamine-extended glycans (FA4G4Lac1S4 at ~12 % and FA4G4Lac2S4 at ~4.5 %), as well as tri- and tetra-lactosamine variants at trace levels (0.75 % and 0.25 %, respectively). High mass accuracy (<5 ppm) and enhanced sensitivity enabled confident assignments without multidimensional fractionation.
Benefits and Practical Applications
The RapiFluor-MS workflow compresses glycan sample preparation to 30 minutes while boosting detection limits through improved fluorescence and MS response. The single-dimension HILIC separation simplifies analysis and accelerates throughput, offering an efficient platform for biosimilar comparability studies, lot release testing, and detailed quality attribute monitoring in biopharmaceutical manufacturing.
Future Trends and Possibilities
Advancements may include integration with ultra-high-throughput automation, coupling with ion mobility for enhanced glycan isomer separation, and expansion to O-glycan analysis. Machine-learning-driven spectral interpretation could further streamline data processing and accelerate regulatory submissions for next-generation glycoprotein therapeutics.
Conclusion
The combination of rapid RapiFluor-MS labeling and HILIC-ESI-QTof-MS offers a sensitive, high-resolution method for characterizing complex EPO N-glycans. This single-dimension approach supports fast, reliable glycan profiling essential for therapeutic development and quality assurance of erythropoietin products.
Reference
- Dube S, Fisher JW, Powell JS. Glycosylation at specific sites of erythropoietin is essential for biosynthesis, secretion, and biological function. J Biol Chem. 1988;263(33):17516–21.
- Sasaki H, Bothner B, Dell A, Fukuda M. Carbohydrate structure of erythropoietin expressed in Chinese hamster ovary cells by a human erythropoietin cDNA. J Biol Chem. 1987;262(25):12059–76.
- Hashii N, Harazono A, Kuribayashi R, et al. Characterization of N-glycan heterogeneities of erythropoietin products by LC/MS and multivariate analysis. Rapid Commun Mass Spectrom. 2014;28(8):921–32.
- Takeuchi M, Inoue N, Strickland TW, et al. Relationship between sugar chain structure and biological activity of recombinant human erythropoietin. Proc Natl Acad Sci USA. 1989;86(20):7819–22.
- Bones J, McLoughlin N, Hilliard M, et al. 2D-LC analysis of BRP 3 erythropoietin N-glycosylation using anion exchange and HILIC-UPLC reveals long poly-N-acetyl lactosamine extensions. Anal Chem. 2011;83(11):4154–62.
- Lauber MA, Yu YQ, Brousmiche DW, et al. Rapid preparation of released N-glycans for HILIC analysis using a labeling reagent that facilitates sensitive fluorescence and ESI-MS detection. Anal Chem. 2015;87(10):5401–8.
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.
Similar PDF
Comprehensive Characterization of the N and O-Linked Glycosylation of a Recombinant Human EPO
2015|Waters|Applications
Comprehensive Characterization of the N and O-Linked Glycosylation of a Recombinant Human EPO Matthew A. Lauber, Stephan M. Koza, and Erin E. Chambers Waters Corporation, Milford, MA, USA A P P L I C AT I O N B E…
Key words
linked, linkedrapifluor, rapifluorrhepo, rhepoglycan, glycanepo, epoglycans, glycansglycosylation, glycosylationrecombinant, recombinanthilic, hilichuman, humanglycoworks, glycoworkserythropoietin, erythropoietindeglycosylated, deglycosylatedcharacterization, characterizationcomprehensive
Waters Application Notes - Glycans
2016|Waters|Guides
Waters Application Notes Glycans There are a variety of complementary techniques practiced to get the complete story about a glycoprotein. Each technique varies in complexity and provides a different layer of information. Method complexity This application notebook highlights a body…
Key words
glycan, glycanrapifluor, rapifluorglycans, glycanshilic, hilicuplc, uplcacquity, acquityamide, amideglycoworks, glycoworksflr, flrreleased, releasedunifi, unifilabeled, labeledseparations, separationsglycosylation, glycosylationbeh
BIOSEPARATIONS - APPLICATIONS NOTEBOOK
2017|Waters|Guides
MAIN MENU TABLE OF CONTENTS [ APPLICATIONS NOTEBOOK ] BIOSEPARATIONS Tools, Techniques, and Insights into Biopharmaceutical Analysis INT RODUCTION Biopharmaceuticals have emerged as a dominant class due to their specificity and efficacy. T he production of biopharmaceuticals, however, is distinctly…
Key words
menu, menuuplc, uplcglycan, glycanacquity, acquitymain, mainrapifluor, rapifluorcontents, contentsglycans, glycanstable, tablehilic, hilicclass, classbio, bioseparations, separationsblend, blendglycoworks
Enhancing the Peak Capacity of High Molecular Weight N-Glycan HILIC Separations with a Wide-Pore Amide Bonded Stationary Phase
2015|Waters|Applications
Enhancing the Peak Capacity of High Molecular Weight N-Glycan HILIC Separations with a Wide-Pore Amide Bonded Stationary Phase Matthew A. Lauber and Stephan M. Koza G OA L Wide-pore glycoprotein BEH amide, 300Å, 1.7 µm To demonstrate the enhanced resolving…
Key words
glycans, glycansglycan, glycanmanoses, manosesglycoprotein, glycoproteinamide, amideneuac, neuacpore, poreglcnac, glcnacrapifluor, rapifluorhilic, hiliclabeled, labeledfucose, fucosegalactose, galactosetri, tricapacity